Amphastar Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$781.10 | $636.99 | 10.61% | 9 | $703.59B |
| NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr902.60 | kr696.07 | 6.36% | 14 | kr4.03T |
| SUNPHARMA | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.50k | Rp1.52k | 5.52% | 25 | Rp3.60T |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$14.05 | $11.59 | 13.88% | 9 | $15.91B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.24 | £28.11 | 51.82% | 9 | £4.27B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr633.00 | kr357.00 | 28.75% | 2 | kr39.42B |
| HALO | Halozyme Therapeutics | Outperform |
11
|
$38.10 | $47.50 | 27.30% | 3 | $4.84B |
| PBH | Prestige Consumer Healthcare | Outperform |
16
|
$71.76 | $71.50 | 3.82% | 3 | $3.56B |
| BHC | Bausch Health Companies | Hold |
15
|
$8.76 | $9.50 | 8.45% | 5 | $3.21B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.05 | $6.13 | 23.97% | 1 | $1.87B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.10 | $41.00 | 32.89% | 0 | $1.65B |
| ANIP | ANI Pharmaceuticals | Buy |
13
|
$66.00 | $69.75 | 21.21% | 1 | $1.38B |
| XERS | Xeris Biopharma Holdings | Buy |
6
|
$1.75 | $4.60 | 171.43% | 1 | $244.39M |
| EBS | Emergent BioSolutions | Outperform |
16
|
$1.88 | $5.00 | 165.96% | 0 | $106.88M |
| ASRT | Assertio Holdings | Buy |
8
|
$0.89 | $3.50 | 237.08% | 2 | $88.49M |
| EGRX | Eagle Pharmaceuticals | - |
14
|
$4.09 | $17.00 | -100.00% | 0 | $84.16M |
| OPNT | Opiant Pharmaceuticals | - |
10
|
$20.77 | $21.00 | -100.00% | 0 | $63.99M |
| LCI | Lannett Company | - |
10
|
$0.03 | $4.00 | -100.00% | 1 | $21.85M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| ENDP.Q | Endo International | - |
14
|
$0.00 | $1.33 | 0.00% | 0 | $1.18M |
| DMK | DMK Pharmaceuticals | - |
8
|
$0.04 | $1.50 | -100.00% | 0 | $0.35M |